Patent · US Expired

Peptidyl compounds having MMP and TNF inhibitory activity

US5955435A · kind A · utility

15Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 8, 1997
Grant dateSep 21, 1999
Priority date
Expiry dateAug 8, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/48
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Peptidyl compounds have therapeutic utility via MMP and TNF inhibitory activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.